設計與合成 (1)三氟甲基酮 (2)C2-對稱雙醇 作為SARS冠狀病毒3CL蛋白酶抑制劑，以及生物活性並在結構上的研究

Design, Synthesis, Biological Activity, and Complexed Structure of SARS-CoV 3CL Protease Inhibitors: (i) Trifluoromethyl Ketones and (ii) C2-Symmetric Diols

邵奕鳴(Yi-Ming Shao)

指導教授 ： 翁啟惠

共同指導教授 ： 林俊宏(Chun-Hung Lin)

國立臺灣大學/生命科學院/生化科學研究所/碩士(2006年)

https://doi.org/10.6342/NTU.2006.00494

摘要

無資料

關鍵字

蛋白酶抑制劑 ； 三氟甲基酮 ； C2-對稱雙醇 ； 電腦模型 ； X光結晶學

並列摘要

Severe acute respiratory syndrome (SARS) is a new viral infectious disease caused by a novel coronavirus (SARS-CoV). Currently, no effective antiviral agents exist against this type of virus. This thesis comprises the design, synthesis, biological activity, and complexed structures of two types of small molecules as inhibitors of SARS-CoV 3CL protease: (i) trifluoromethyl ketones and (ii) C2-symmetric diols.
Trifluoromethyl ketones are known to be reversible inhibitors of some serine proteases, such as elastase and chymotrypsin. The best one of a series of trifluoromethyl ketones synthesized is a tetrapeptidyl trifluoromethyl ketone with Ki value of 0.286 μM against SARS-CoV 3CL protease, a cysteine protease. In addition, TL-3, a potent inhibitor of HIV protease, was previously found to show inhibition (Ki = 0.6 μM) against SARS-CoV 3CL protease. Without guidance of the crystal structure of this enzyme in complex with TL-3, optimization of this inhibitor was performed based on computational modeling prediction. Aided by modeling, two novel TL-3 derivatives 163 and 168 with indole instead of benzyl group as the core were synthesized. These two new compounds were proved to be more effective inhibitors (Ki = 0.340 and 0.073 μM, respectively) than TL-3 for SARS-CoV 3CL protease.
The interactions between 163 and SARS-CoV 3CL protease were determined using the combination of X-ray crystallography and computer modeling, and an molecular insight of small molecule-biological target interactions was disclosed.

並列關鍵字

protease inhibitors ； trifluoromethyl ketones ； C2-symmetric diols ； computer modeling ； X-ray crystallography

參考文獻

Chapter One

2. Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003).

3. Peiris, J.S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).

4. Rota, P.A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394–1399 (2003).

5. Marra, M.A. et al. The genome sequence of the SARS-associated coronavirus. Science 300, 1399–1404 (2003).